Tumor Organoids Improve Mutation Detection of Pancreatic Ductal Adenocarcinoma

Researchers investigated the utility of patient-derived organoids (PDOs) to overcome the obstacles of detecting somatic mutations and enhance somatic mutation identification. Surgically resected pancreatic ductal adenocarcinoma tumors and their paired PDOs from 21 patients were examined.